Brenda F. Kurland, Ph.D. - Publications

Affiliations: 
2002 University of Washington, Seattle, Seattle, WA 
Area:
Biostatistics Biology

64 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Metz HE, Kargl J, Busch SE, Kim KH, Kurland BF, Abberbock SR, Randolph-Habecker J, Knoblaugh SE, Kolls JK, White MF, Houghton AM. Insulin receptor substrate-1 deficiency drives a proinflammatory phenotype in KRAS mutant lung adenocarcinoma. Proceedings of the National Academy of Sciences of the United States of America. PMID 27439864 DOI: 10.1073/pnas.1601989113  0.76
2016 Rodler ET, Kurland BF, Griffin M, Gralow JR, Porter P, Yeh RF, Gadi VK, Guenthoer J, Beumer JH, Korde L, Stychor S, Kiesel B, Linden HM, Thompson JA, Swisher EM, et al. Phase I Study of Veliparib (ABT-888) Combined with Cisplatin and Vinorelbine in Advanced Triple-Negative Breast Cancer and/or BRCA Mutation-Associated Breast Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26801247 DOI: 10.1158/1078-0432.CCR-15-2137  0.76
2016 Kurland BF, Muzi M, Peterson LM, Doot RK, Wangerin KA, Mankoff DA, Linden HM, Kinahan PE. Multicenter Clinical Trials Using 18F-FDG PET to Measure Early Response to Oncologic Therapy: Effects of Injection-to-Acquisition Time Variability on Required Sample Size. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 57: 226-30. PMID 26493206 DOI: 10.2967/jnumed.115.162289  0.76
2016 Rahbar H, Kurland BF, Olson ML, Kitsch AE, Scheel JR, Chai X, Usoro J, Lehman CD, Partridge SC. Diffusion-Weighted Breast Magnetic Resonance Imaging: A Semiautomated Voxel Selection Technique Improves Interreader Reproducibility of Apparent Diffusion Coefficient Measurements Journal of Computer Assisted Tomography. DOI: 10.1097/RCT.0000000000000372  0.76
2015 Nedrow JR, Latoche JD, Day KE, Modi J, Ganguly T, Zeng D, Kurland BF, Berkman CE, Anderson CJ. Targeting PSMA with a Cu-64 Labeled Phosphoramidate Inhibitor for PET/CT Imaging of Variant PSMA-Expressing Xenografts in Mouse Models of Prostate Cancer. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 26552656 DOI: 10.1007/s11307-015-0908-7  0.76
2015 Wang P, Bahreini A, Gyanchandani R, Lucas P, Hartmaier RJ, Watters RJ, Jonnalagadda AR, Trejo Bittar HE, Berg A, Hamilton RL, Kurland BF, Weiss K, Mathew A, Leone JP, Davidson NE, et al. Sensitive detection of mono- and polyclonal ESR1 mutations in primary tumors, metastatic lesions and cell free DNA of breast cancer patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26500237 DOI: 10.1158/1078-0432.CCR-15-1534  0.76
2015 Partridge SC, Kurland BF, Liu CL, Ho RJ, Ruddell A. Tumor-induced lymph node alterations detected by MRI lymphography using gadolinium nanoparticles. Scientific Reports. 5: 15641. PMID 26497382 DOI: 10.1038/srep15641  0.76
2015 Weissfeld JL, Lin Y, Lin HM, Kurland BF, Wilson DO, Fuhrman CR, Pennathur A, Romkes M, Nukui T, Yuan JM, Siegfried JM, Diergaarde B. Lung cancer risk prediction using common SNPs located in GWAS-identified susceptibility regions. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 26352532 DOI: 10.1097/JTO.0000000000000666  0.76
2015 Cho E, Mostaghel EA, Russell KJ, Liao JJ, Konodi MA, Kurland BF, Marck BT, Matsumoto AM, Dalkin BL, Montgomery RB. External beam radiation therapy and abiraterone in men with localized prostate cancer: safety and effect on tissue androgens. International Journal of Radiation Oncology, Biology, Physics. 92: 236-43. PMID 25772183 DOI: 10.1016/j.ijrobp.2015.01.020  0.76
2015 Raunig DL, McShane LM, Pennello G, Gatsonis C, Carson PL, Voyvodic JT, Wahl RL, Kurland BF, Schwarz AJ, Gönen M, Zahlmann G, Kondratovich MV, O'Donnell K, Petrick N, Cole PE, et al. Quantitative imaging biomarkers: a review of statistical methods for technical performance assessment. Statistical Methods in Medical Research. 24: 27-67. PMID 24919831 DOI: 10.1177/0962280214537344  0.76
2015 Ceschin R, Kurland BF, Abberbock SR, Ellingson BM, Okada H, Jakacki RI, Pollack IF, Panigrahy A. Parametric response mapping of apparent diffusion coefficient as an imaging biomarker to distinguish pseudoprogression from true tumor progression in peptide-based vaccine therapy for pediatric diffuse intrinsic pontine glioma American Journal of Neuroradiology. 36: 2170-2176. DOI: 10.3174/ajnr.A4428  0.76
2015 Wu S, Kurland BF, Berg WA, Zuley ML, Jankowitz RC, Sumkin J, Gur D. Signal enhancement ratio (SER) quantified from breast DCE-MRI and breast cancer risk Progress in Biomedical Optics and Imaging - Proceedings of Spie. 9414. DOI: 10.1117/12.2082466  0.76
2014 Inamoto Y, Pidala J, Chai X, Kurland BF, Weisdorf D, Flowers ME, Palmer J, Arai S, Jacobsohn D, Cutler C, Jagasia M, Goldberg JD, Martin PJ, Pavletic SZ, Vogelsang GB, et al. Assessment of joint and fascia manifestations in chronic graft-versus-host disease. Arthritis & Rheumatology (Hoboken, N.J.). 66: 1044-52. PMID 24757155 DOI: 10.1002/art.38293  0.76
2014 Palmer J, Williams K, Inamoto Y, Chai X, Martin PJ, Tomas LS, Cutler C, Weisdorf D, Kurland BF, Carpenter PA, Pidala J, Pavletic SZ, Wood W, Jacobsohn D, Arai S, et al. Pulmonary symptoms measured by the national institutes of health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 337-44. PMID 24315845 DOI: 10.1016/j.bbmt.2013.11.025  0.76
2014 Peterson LM, Kurland BF, Schubert EK, Link JM, Gadi VK, Specht JM, Eary JF, Porter P, Shankar LK, Mankoff DA, Linden HM. A phase 2 study of 16α-[18F]-fluoro-17β-estradiol positron emission tomography (FES-PET) as a marker of hormone sensitivity in metastatic breast cancer (MBC). Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 16: 431-40. PMID 24170452 DOI: 10.1007/s11307-013-0699-7  0.76
2013 Kurland BF, Doot RK, Linden HM, Mankoff DA, Kinahan PE. Multicenter trials using ¹⁸F-fluorodeoxyglucose (FDG) PET to predict chemotherapy response: effects of differential measurement error and bias on power calculations for unselected and enrichment designs. Clinical Trials (London, England). 10: 886-95. PMID 24169628 DOI: 10.1177/1740774513506618  0.76
2013 Qu X, Randhawa G, Friedman C, Kurland BF, Glaskova L, Coleman I, Mostaghel E, Higano CS, Porter C, Vessella R, Nelson PS, Fang M. A three-marker FISH panel detects more genetic aberrations of AR, PTEN and TMPRSS2/ERG in castration-resistant or metastatic prostate cancers than in primary prostate tumors. Plos One. 8: e74671. PMID 24098661 DOI: 10.1371/journal.pone.0074671  0.76
2013 Bauman JE, Austin MC, Schmidt R, Kurland BF, Vaezi A, Hayes DN, Mendez E, Parvathaneni U, Chai X, Sampath S, Martins RG. ERCC1 is a prognostic biomarker in locally advanced head and neck cancer: results from a randomised, phase II trial. British Journal of Cancer. 109: 2096-105. PMID 24064970 DOI: 10.1038/bjc.2013.576  0.76
2013 Martins RG, Parvathaneni U, Bauman JE, Sharma AK, Raez LE, Papagikos MA, Yunus F, Kurland BF, Eaton KD, Liao JJ, Mendez E, Futran N, Wang DX, Chai X, Wallace SG, et al. Cisplatin and radiotherapy with or without erlotinib in locally advanced squamous cell carcinoma of the head and neck: a randomized phase II trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 1415-21. PMID 23460709 DOI: 10.1200/JCO.2012.46.3299  0.76
2013 Pidala J, Chai X, Kurland BF, Inamoto Y, Flowers ME, Palmer J, Khera N, Jagasia M, Cutler C, Arora M, Vogelsang G, Lee SJ. Analysis of gastrointestinal and hepatic chronic graft-versus-host [corrected] disease manifestations on major outcomes: a chronic graft-versus-host [corrected] disease consortium study. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 784-91. PMID 23395601 DOI: 10.1016/j.bbmt.2013.02.001  0.76
2012 Kurland BF, Johnson LL, Diehr PH. Accommodation of missing data in supportive and palliative care clinical trials. Current Opinion in Supportive and Palliative Care. 6: 465-70. PMID 23042422 DOI: 10.1097/SPC.0b013e328358441d  0.76
2012 Kurland BF, Gerstner ER, Mountz JM, Schwartz LH, Ryan CW, Graham MM, Buatti JM, Fennessy FM, Eikman EA, Kumar V, Forster KM, Wahl RL, Lieberman FS. Promise and pitfalls of quantitative imaging in oncology clinical trials. Magnetic Resonance Imaging. 30: 1301-12. PMID 22898682 DOI: 10.1016/j.mri.2012.06.009  0.76
2012 Muzi M, O'Sullivan F, Mankoff DA, Doot RK, Pierce LA, Kurland BF, Linden HM, Kinahan PE. Quantitative assessment of dynamic PET imaging data in cancer imaging. Magnetic Resonance Imaging. 30: 1203-15. PMID 22819579 DOI: 10.1016/j.mri.2012.05.008  0.76
2012 Jacobsohn DA, Kurland BF, Pidala J, Inamoto Y, Chai X, Palmer JM, Arai S, Arora M, Jagasia M, Cutler C, Weisdorf D, Martin PJ, Pavletic SZ, Vogelsang G, Lee SJ, et al. Correlation between NIH composite skin score, patient-reported skin score, and outcome: results from the Chronic GVHD Consortium. Blood. 120: 2545-52; quiz 2774. PMID 22773386 DOI: 10.1182/blood-2012-04-424135  0.76
2012 Kurland BF, Gadi VK, Specht JM, Allison KH, Livingston RB, Rodler ET, Peterson LM, Schubert EK, Chai X, Mankoff DA, Linden HM. Feasibility study of FDG PET as an indicator of early response to aromatase inhibitors and trastuzumab in a heterogeneous group of breast cancer patients. Ejnmmi Research. 2: 34. PMID 22731662 DOI: 10.1186/2191-219X-2-34  0.76
2012 Inamoto Y, Chai X, Kurland BF, Cutler C, Flowers ME, Palmer JM, Carpenter PA, Heffernan MJ, Jacobsohn D, Jagasia MH, Pidala J, Khera N, Vogelsang GB, Weisdorf D, Martin PJ, et al. Validation of measurement scales in ocular graft-versus-host disease. Ophthalmology. 119: 487-93. PMID 22153706 DOI: 10.1016/j.ophtha.2011.08.040  0.76
2012 Doot RK, Kurland BF, Kinahan PE, Mankoff DA. Design considerations for using PET as a response measure in single site and multicenter clinical trials. Academic Radiology. 19: 184-90. PMID 22104290 DOI: 10.1016/j.acra.2011.10.008  0.76
2011 Peterson LM, Kurland BF, Link JM, Schubert EK, Stekhova S, Linden HM, Mankoff DA. Factors influencing the uptake of 18F-fluoroestradiol in patients with estrogen receptor positive breast cancer. Nuclear Medicine and Biology. 38: 969-78. PMID 21982568 DOI: 10.1016/j.nucmedbio.2011.03.002  0.76
2011 Kurland BF, Peterson LM, Lee JH, Linden HM, Schubert EK, Dunnwald LK, Link JM, Krohn KA, Mankoff DA. Between-patient and within-patient (site-to-site) variability in estrogen receptor binding, measured in vivo by 18F-fluoroestradiol PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 1541-9. PMID 21903739 DOI: 10.2967/jnumed.111.091439  0.76
2011 Linden HM, Kurland BF, Peterson LM, Schubert EK, Gralow JR, Specht JM, Ellis GK, Lawton TJ, Livingston RB, Petra PH, Link JM, Krohn KA, Mankoff DA. Fluoroestradiol positron emission tomography reveals differences in pharmacodynamics of aromatase inhibitors, tamoxifen, and fulvestrant in patients with metastatic breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 4799-805. PMID 21750198 DOI: 10.1158/1078-0432.CCR-10-3321  0.76
2011 Pidala J, Kurland BF, Chai X, Vogelsang G, Weisdorf DJ, Pavletic S, Cutler C, Majhail N, Lee SJ. Sensitivity of changes in chronic graft-versus-host disease activity to changes in patient-reported quality of life: results from the Chronic Graft-versus-Host Disease Consortium. Haematologica. 96: 1528-35. PMID 21685473 DOI: 10.3324/haematol.2011.046367  0.76
2011 Syrjala KL, Artherholt SB, Kurland BF, Langer SL, Roth-Roemer S, Elrod JB, Dikmen S. Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 2397-404. PMID 21537032 DOI: 10.1200/JCO.2010.33.9119  0.76
2011 Dunnwald LK, Doot RK, Specht JM, Gralow JR, Ellis GK, Livingston RB, Linden HM, Gadi VK, Kurland BF, Schubert EK, Muzi M, Mankoff DA. PET tumor metabolism in locally advanced breast cancer patients undergoing neoadjuvant chemotherapy: value of static versus kinetic measures of fluorodeoxyglucose uptake. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 2400-9. PMID 21364034 DOI: 10.1158/1078-0432.CCR-10-2649  0.76
2011 Demartini WB, Kurland BF, Gutierrez RL, Blackmore CC, Peacock S, Lehman CD. Probability of malignancy for lesions detected on breast MRI: a predictive model incorporating BI-RADS imaging features and patient characteristics. European Radiology. 21: 1609-17. PMID 21359910 DOI: 10.1007/s00330-011-2094-6  0.76
2011 Partridge SC, Rahbar H, Murthy R, Chai X, Kurland BF, Demartini WB, Lehman CD. Improved diagnostic accuracy of breast MRI through combined apparent diffusion coefficients and dynamic contrast-enhanced kinetics Magnetic Resonance in Medicine. 65: 1759-1767. PMID 21254208 DOI: 10.1002/mrm.22762  0.76
2010 Partridge SC, Vanantwerp RK, Doot RK, Chai X, Kurland BF, Eby PR, Specht JM, Dunnwald LK, Schubert EK, Lehman CD, Mankoff DA. Association between serial dynamic contrast-enhanced MRI and dynamic 18F-FDG PET measures in patients undergoing neoadjuvant chemotherapy for locally advanced breast cancer. Journal of Magnetic Resonance Imaging : Jmri. 32: 1124-31. PMID 21031518 DOI: 10.1002/jmri.22362  0.76
2010 Partridge SC, Mullins CD, Kurland BF, Allain MD, DeMartini WB, Eby PR, Lehman CD. Apparent diffusion coefficient values for discriminating benign and malignant breast MRI lesions: effects of lesion type and size. Ajr. American Journal of Roentgenology. 194: 1664-73. PMID 20489111 DOI: 10.2214/AJR.09.3534  0.76
2010 Specht JM, Kurland BF, Montgomery SK, Dunnwald LK, Doot RK, Gralow JR, Ellis GK, Linden HM, Livingston RB, Allison KH, Schubert EK, Mankoff DA. Tumor metabolism and blood flow as assessed by positron emission tomography varies by tumor subtype in locally advanced breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 2803-10. PMID 20460489 DOI: 10.1158/1078-0432.CCR-10-0026  0.76
2010 Partridge SC, Demartini WB, Kurland BF, Eby PR, White SW, Lehman CD. Differential diagnosis of mammographically and clinically occult breast lesions on diffusion-weighted MRI. Journal of Magnetic Resonance Imaging : Jmri. 31: 562-70. PMID 20187198 DOI: 10.1002/jmri.22078  0.76
2010 Eby PR, Calhoun KE, Kurland BF, Demartini WB, Gutierrez RL, Peacock S, Anderson BO, Byrd DR, Mann GN, Lehman CD. Preoperative and intraoperative sonographic visibility of collagen-based breast biopsy marker clips. Academic Radiology. 17: 340-7. PMID 20042350 DOI: 10.1016/j.acra.2009.10.017  0.76
2009 Kurland BF, Johnson LL, Egleston BL, Diehr PH. Longitudinal Data with Follow-up Truncated by Death: Match the Analysis Method to Research Aims. Statistical Science : a Review Journal of the Institute of Mathematical Statistics. 24: 211. PMID 20119502 DOI: 10.1214/09-STS293  0.76
2009 Partridge SC, DeMartini WB, Kurland BF, Eby PR, White SW, Lehman CD. Quantitative diffusion-weighted imaging as an adjunct to conventional breast MRI for improved positive predictive value. Ajr. American Journal of Roentgenology. 193: 1716-22. PMID 19933670 DOI: 10.2214/AJR.08.2139  0.76
2009 Gutierrez RL, DeMartini WB, Eby PR, Kurland BF, Peacock S, Lehman CD. BI-RADS lesion characteristics predict likelihood of malignancy in breast MRI for masses but not for nonmasslike enhancement. Ajr. American Journal of Roentgenology. 193: 994-1000. PMID 19770321 DOI: 10.2214/AJR.08.1983  0.76
2009 Gutierrez RL, Demartini WB, Eby P, Kurland BF, Peacock S, Lehman CD. Clinical indication and patient age predict likelihood of malignancy in suspicious breast MRI lesions. Academic Radiology. 16: 1281-5. PMID 19733804 DOI: 10.1016/j.acra.2009.04.012  0.76
2009 Deng Y, Kurland BF, Wang J, Bi J, Li W, Rao S, Lan P, Lin T, Lin E. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor. American Journal of Clinical Oncology. 32: 245-52. PMID 19451802 DOI: 10.1097/COC.0b013e3181891326  0.76
2009 Price JL, McKeel DW, Buckles VD, Roe CM, Xiong C, Grundman M, Hansen LA, Petersen RC, Parisi JE, Dickson DW, Smith CD, Davis DG, Schmitt FA, Markesbery WR, Kaye J, ... ... Kurland BF, et al. Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiology of Aging. 30: 1026-36. PMID 19376612 DOI: 10.1016/j.neurobiolaging.2009.04.002  0.76
2008 Bauman JE, Mulligan MS, Martins RG, Kurland BF, Eaton KD, Wood DE. Salvage lung resection after definitive radiation (>59 Gy) for non-small cell lung cancer: surgical and oncologic outcomes. The Annals of Thoracic Surgery. 86: 1632-8; discussion 1. PMID 19049763 DOI: 10.1016/j.athoracsur.2008.07.042  0.76
2008 Eby PR, Partridge SC, White SW, Doot RK, Dunnwald LK, Schubert EK, Kurland BF, Lehman CD, Mankoff DA. Metabolic and vascular features of dynamic contrast-enhanced breast magnetic resonance imaging and (15)O-water positron emission tomography blood flow in breast cancer. Academic Radiology. 15: 1246-54. PMID 18790395 DOI: 10.1016/j.acra.2008.03.019  0.76
2008 Dunnwald LK, Gralow JR, Ellis GK, Livingston RB, Linden HM, Specht JM, Doot RK, Lawton TJ, Barlow WE, Kurland BF, Schubert EK, Mankoff DA. Tumor metabolism and blood flow changes by positron emission tomography: relation to survival in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 4449-57. PMID 18626006 DOI: 10.1200/JCO.2007.15.4385  0.76
2008 Goff BA, Holmberg LA, Veljovich D, Kurland BF. Treatment of recurrent or persistent platinum-refractory ovarian, fallopian tube or primary peritoneal cancer with gemcitabine and topotecan: a phase II trial of the Puget Sound Oncology Consortium. Gynecologic Oncology. 110: 146-51. PMID 18538834 DOI: 10.1016/j.ygyno.2008.04.037  0.76
2008 Koepsell TD, Kurland BF, Harel O, Johnson EA, Zhou XH, Kukull WA. Education, cognitive function, and severity of neuropathology in Alzheimer disease Neurology. 70: 1732-1739. PMID 18160675 DOI: 10.1212/01.wnl.0000284603.85621.aa  0.76
2008 Mehta KM, Yaffe K, Pérez-Stable EJ, Stewart A, Barnes D, Kurland BF, Miller BL. Race/ethnic differences in AD survival in US Alzheimer's Disease Centers Neurology. 70: 1163-1170. PMID 18003939 DOI: 10.1212/01.wnl.0000285287.99923.3c  0.76
2008 Syrjala KL, Kurland BF, Abrams JR, Sanders JE, Heiman JR. Sexual function changes during the 5 years after high-dose treatment and hematopoietic cell transplantation for malignancy, with case-matched controls at 5 years. Blood. 111: 989-96. PMID 17878404 DOI: 10.1182/blood-2007-06-096594  0.76
2007 Yao MS, Kurland BF, Smith AH, Schubert EK, Dunnwald LK, Byrd DR, Mankoff DA. Internal mammary nodal chain drainage is a prognostic indicator in axillary node-positive breast cancer. Annals of Surgical Oncology. 14: 2985-93. PMID 17564747 DOI: 10.1245/s10434-007-9473-x  0.76
2007 Doot RK, Dunnwald LK, Schubert EK, Muzi M, Peterson LM, Kinahan PE, Kurland BF, Mankoff DA. Dynamic and static approaches to quantifying 18F-FDG uptake for measuring cancer response to therapy, including the effect of granulocyte CSF. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 48: 920-5. PMID 17504870 DOI: 10.2967/jnumed.106.037382  0.76
2007 Specht JM, Tam SL, Kurland BF, Gralow JR, Livingston RB, Linden HM, Ellis GK, Schubert EK, Dunnwald LK, Mankoff DA. Serial 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP). Breast Cancer Research and Treatment. 105: 87-94. PMID 17268819 DOI: 10.1007/s10549-006-9435-1  0.76
2006 Kurland BF, Gill TM, Patrick DL, Larson EB, Phelan EA. Longitudinal change in positive affect in community-dwelling older persons. Journal of the American Geriatrics Society. 54: 1846-53. PMID 17198489 DOI: 10.1111/j.1532-5415.2006.00970.x  0.76
2005 Kurland BF, Heagerty PJ. Directly parameterized regression conditioning on being alive: analysis of longitudinal data truncated by deaths. Biostatistics (Oxford, England). 6: 241-58. PMID 15772103 DOI: 10.1093/biostatistics/kxi006  0.76
2004 Kurland BF, Heagerty PJ. Marginalized transition models for longitudinal binary data with ignorable and non-ignorable drop-out. Statistics in Medicine. 23: 2673-95. PMID 15316952 DOI: 10.1002/sim.1850  0.76
2003 Gill TM, Kurland BF. Prognostic effect of prior disability episodes among nondisabled community-living older persons. American Journal of Epidemiology. 158: 1090-6. PMID 14630605 DOI: 10.1093/aje/kwg237  0.76
2002 Ashmore JL, Kurland BF, King GJ, Wheeler TT, Ghafari J, Ramsay DS. A 3-dimensional analysis of molar movement during headgear treatment. American Journal of Orthodontics and Dentofacial Orthopedics : Official Publication of the American Association of Orthodontists, Its Constituent Societies, and the American Board of Orthodontics. 121: 18-29; discussion 29. PMID 11786867 DOI: 10.1067/mod.2002.120687  0.76
2001 Heagerty PJ, Kurland BF. Misspecified maximum likelihood estimates and generalised linear mixed models Biometrika. 88: 973-985.  0.76
1997 Kurland BF, Snow CE. Longitudinal measurement of growth in definitional skill. Journal of Child Language. 24: 603-25. PMID 9519587  0.76
1995 Snow CE, Tabors PO, Nicholson PA, Kurland BF. Shell: Oral language and early literacy skills in kindergarten and first-grade children Journal of Research in Childhood Education. 10: 37-48. DOI: 10.1080/02568549509594686  0.76
Show low-probability matches.